Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $32.9000 (-2.08%) ($32.9000 - $34.7900) on Thu. Oct. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.79% (three month average) | RSI | 42 | Latest Price | $32.9000(-2.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) PEJ(7%) VT(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -1.895% in a week (0% probabilities). IPO(-6%) VIXM(-5%) TLT(-5%) GLD(-5%) GDX(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.895% (StdDev 3.79%) | Hourly BBV | 0 () | Intraday Trend | -4.6% | | | |
|
Resistance Level | $34.1 | 5 Day Moving Average | $33.88(-2.89%) | 10 Day Moving Average | $33.49(-1.76%) | 20 Day Moving Average | $34.1(-3.52%) | To recent high | -23% | To recent low | 4.1% | Market Cap | $648m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |